Skip to content

The effect of cold pack on the complications of enoxaparin injection

The effect of the cold pack on bruising and pain caused by subcutaneous injection of enoxaparin sodium on elderly patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160606028289N2
Enrollment
88
Registered
2018-12-17
Start date
2018-11-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention 1: Intervention group: Elderly patients with a MMSE =25 and receiving enoxaparin, are randomly assigned to the right and left abdomen to the control and intervention groups. In the interv

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: Receiving enoxaparin Being aware according MMSE Being hospitalized at least for 3 days Having informed consent Non-injecting drug or other anticoagulant in the abdomen wall Not having cold skin allergy Normal PT, PTT, INR and platelets

Exclusion criteria

Exclusion criteria: Discharge earlier than 3 days Skin allergy to the cold pack during intervention Reluctance to continue cooperation Bleeding from the injection site Decreased consciousness in the study process

Design outcomes

Primary

MeasureTime frame
The complications of Enoxaparin injection. Timepoint: During, 24, 48 and 72 hours after injection. Method of measurement: The using of the Visual Analogue Scale and Transparent millimeter ruler.

Secondary

MeasureTime frame
The Score of the patients' pain. Timepoint: The measurement of pain during injection. Method of measurement: According to Visual Analogue Scale.;The measurement of Bruising size. Timepoint: 24, 48 and 72 hours after Enoxaparin injection. Method of measurement: Transparent millimeter ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Esmaeilpour-Bandboni

Rasht University of Medical Sciences

esmaeilmmm@yahoo.com+98 13 4242 4368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026